期刊文献+

巨噬细胞移动抑制因子与受体CD74在胎盘组织中的表达及其与子痫前期发病的关系 被引量:3

Expression of macrophage migration inhibitory factor and CD_(74) in preeclamptic placenta and its correlation with preeclampsia
原文传递
导出
摘要 目的 探讨巨噬细胞移动抑制因子(MIF)与受体CD74在胎盘组织中的表达及其与子痫前期发病的关系.方法 选取2008年3-11月在青岛大学医学院附属医院产科住院分娩的子痫前期孕产妇69例,其中轻度子痫前期孕产妇33例(轻度子痫前期组),重度子痫前期孕产妇36例(重度子痫前期组).另选取同期正常妊娠晚期孕产妇43例为对照组.采用免疫比浊法榆测3组孕产妇血中C反应蛋白水平;采用免疫组化链酶菌抗生物素蛋白-过氧化物酶连接(SP)法榆测3组孕产妇胎枯组织中的MIF和CD74的表达;采用逆转录(RT)PCR技术检测3组孕产妇胎盘组织中MIFmRNA和CD74mRNA的表达.并对轻度及重度子痫前期组孕产妇血中C反应蛋白水平与胎盘组织中MIF mRNA及CD74 mRNA表达的相关性进行分析.结果 (1)3组孕产妇胎盘组织中均有MIF和CD74的表达,并呈棕黄色染色,轻度及莆度子痫前期组孕产妇胎盘组织中MIF及CD74的表达明显增强.(2)轻度子痫前期组孕产妇胎盘组织中MIF mRNA及CD74mRNA表达水平分别为0.70±0.13及0.96±0.16;重度子痫前期组分别为0.88±0.12及1.08±0.15,两组比较,差异有统计学意义(P〈0.01).对照组孕产妇胎盘组织中MIF mRNA及CD74mRNA表达水平分别为0.67±0.11及0.83±0.14,明显低于轻度及重度子痫前期组,分别比较,差异均有统计学意义(P〈0.01).(3)轻度及重度子痫前期组孕产妇血中C反应蛋白水平分别为(15.3±7.0)及(21.6±9.1)mg/L,两组比较,差异有统计学意义(P〈0.01);对照组为(4.8±1.8)mg/L,明显低于轻度及重度子痫前期组,分别比较,差异均有统计学意义(P〈0.01).(4)轻度及重度子痫前期组孕产妇血中C反应蛋白水平与胎盘组织中MIF mRNA表达呈正相关关系(r=0.67,P〈0.01);与胎盘组织中CD74mRNA表达呈正相关火系(r=0.83,P〈0.01).胎盘组织中MIF mRNA表达与CD74mRNA表达呈正相关关系(r=0.93,P〈0.01).结论 子痫前期患者胎盘组织中的MIF及其受体CD74的过度表达,可上调血中炎性标志物C反应蛋白的水平,引起血管内皮损伤,从而参与子痫前期的发病. Objective To investigate the expression of macrophage migration inhibitory factor (MIF) and CD_(74), the receptor of MIF, in preeclamptic placenta and its correlation with the pathogenesis of preeclampsia.Methods From March 2008 to November 2008,69 preeclamptic women who delivered in the Department of Obstetrics, Affiliated Hospital of Qingdao University Medical College,were recruited,including 33 women with mild preeclampsia (MPE group) and 36 women with severe preeclampsia (SPE group).Another 43 healthy pregnant women were taken as control group.Immunoturbidimetry was applied to measure the concentrations of C-reactive protein (CRP) in maternal blood.The expressions of MIF and CD_(74) in placenta were tested with immunohistochemistry and the expressions of MIF mRNA and CD_(74) mRNA were detected by semiquantitative RT-PCR.The relationship between maternal blood level of CRP and MIF mRNA and CD_(74) mRNA in placenta was analyzed in the MPE and SPE group.Results (1) MIF and CD_(74) were expressed in the placenta of all pregnant women in the 3 groups, as shown in brown-yellow color, and significantly higher expression was found in the MPE and SPE group.(2) The expression of MIF mRNA and CD_(74) mRNA in the MPE group (0.70±0.13 and 0.96±0.16), SPE group (0.88 ± 0.12 and 1.08 ± 0.15) were significantly higher than in the control group (0.67 ± 0.11 and 0.83 ± 0.14) (P 〈 0.01), and statistical significance was also found between the MPE and SPE group (P 〈0.01).(3)The maternal blood concentrations of CRP in the MPE and SPE group were significantly higher than in the control group [(15.3±7.0) mg/L and (21.6±9.1)mg/L vs (4.8 ± 1.8) mg/L, P 〈0.01] , and significant difference was also found between the MPE and SPE group (P 〈0.01).(4) In the two preeclamptic groups, the blood concentrations of CRP were positively correlated with the expression of both MIF mRNA(r =0.67 ,P 〈0.01)and CD_(74) mRNA(r =0.83 ,P 〈0.01) in placenta.Positive correlation was also found between the levels of MIF mRNA and CD_(74) mRNA in placenta (r =0.93 ,P 〈 0.01).Conclusions Overexpression of MIF and CD_(74) in the placenta may up-regulate the CRP level in maternal blood, resulting in systemic inflammatory reaction and vascular endothelium damage which may be involved in the pathogenesis of preeclampsia.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2010年第4期278-282,共5页 Chinese Journal of Obstetrics and Gynecology
关键词 先兆子痫 臣噬细胞游走抑制因子 组织相容性抗原Ⅱ类 抗原 分化 B淋巴细胞 C反应蛋白质 Pre-eclampsia Macrophage migration-inhibitory factors Histocompatibility antigens class Ⅱ Antigens,differentiation,B-lymphocyte C-reactive protein
  • 相关文献

参考文献19

  • 1林其德.对子痫前期的新认识[J].中华妇产科杂志,2009,44(2):81-83. 被引量:19
  • 2Verschuren L,Kooistra T,Bernhagen J,et al.MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance,glucose intolerance,and associated atherosclerotic disease.Circ Res,2009,105:99-107.
  • 3Viganò P,Cintorino M,Schatz F,et al.The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal-maternal interface.Semin Immunapathol,2007,29:135-150.
  • 4乐杰.妇产科学.7版,北京:人民卫生出版社,2009:92-99.
  • 5Bucala R.MIF rediscovered:cytokine,pituitary hormone,and glucocorticoid-induced regulator of the immune response.FASEB J,1996,14:1607-1613.
  • 6Todros T,Bontempo S,Piccoli E,et al.Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia.Eur J Obstet Gynecol Reprod Biol,2005,123:162-166.
  • 7Lue H,Kleemann R,Calandra T,et al.Macrophage migration inhibitory factor (MIF):mechanisms of action and role in disease.Microbes Infect,2002,4:449460.
  • 8Santos LL,Morand EE Macrophage migration inhibitory factor:a key cytokine in RA,SLE and atherosclerosis.Clin Chim Acta,2009,399:1-7.
  • 9Suzuki H,Kanagawa H,Nishihira J.Evidence for the presence of macrophage migration inhibitory factor in murine reproductive organs and early embryos.Immunol Lett,1996,51:141-147.
  • 10Arcuri F,Buchwalder L,Toti P,et al.Differential regulation of colony stimulating factor 1 and macrophage migration inhibitory factor expression by inflammatory cytokines in term human decidua:implications for macrophage trafficking at the fetalmaternal interface.Biol Reprod,2007,76:433-439.

二级参考文献6

  • 1Redman CW, Sargent IL. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol,2007 ,76 :61- 67.
  • 2Sibai BM. Intergenerational factors : missing link for preeclampsia, fetal growth restriction, and cardiovascular disease? Hypertension, 2008,51:993-994.
  • 3Rustveld LO, Kelsey SF, Sharma R. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern Child Health J,2008,12:223-242.
  • 4Laivuori H. Genetic aspects of preeclampsia. Front Biosci, 2007, 12:2372-2382.
  • 5Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy : an inflammatory view. Trends Immunol,2006,27 : 399- 404.
  • 6Knight M, Redman CW, Linton EA, et al. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol, 1998, 105:632- 640.

共引文献44

同被引文献32

  • 1王琳,刘群英,叶元华,吕秀翠.激活素A及抑制素A与子痫前期的相关性[J].齐鲁医学杂志,2006,21(6):471-473. 被引量:2
  • 2单志新,符永恒,余细勇,邓春玉,谭虹虹,林秋雄,于汇民,林曙光.巨噬细胞移动抑制因子-173G/C多态性与冠心病的相关性研究[J].中华医学遗传学杂志,2006,23(5):548-550. 被引量:19
  • 3乐杰.妇产科学[M].7版.北京:人民卫生出版社,2009:92-99.
  • 4乐杰,谢幸,林仲秋,等.妇产科学.7版.北京:人民卫生出版社,2009:100.
  • 5Viganb P, Cintorino M, Schatz F, et al. The role of maerophage migration inhibitory factor in maintaining the immune privilege at the fetal-matenlal interface. Semin Immunopathol,2007,29 : 135-150.
  • 6Grieb G, Merk M, Bernhagen J, et al. Macrophage migration inhibitory factor (MIF):a promising biomarker. Drug News Perspect, 2010, 23:257-264.
  • 7Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis, 2005, 41 Suppl 7:S513-519.
  • 8Papp AC, Pinsonneault JK, Cooke G, et al. Single nucleotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves. Biotechniques, 2003,34 : 1068-1072.
  • 9Wang J, Chuang K, Ahluwalia M, et al. High-throughput SNP genotyping by single-tube PCR with Tin-shift primers. Biotechniques, 2005, 39:885-893.
  • 10Kleemann R, Bucala R. Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Mediators Inflamm, 2010, 2010:610479.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部